The Role of Inflammatory Proteins in Anti-Glucocorticoid Therapy for Treatment-Resistant Depression

Background: Optimising treatments for patients with treatment-resistant depression (TRD) is key to reducing the burden of this severe illness. The anti-glucocorticoid medication metyrapone has mixed evidence supporting a role as a possible augmentation treatment in TRD. The degree of treatment resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Strawbridge, Rebecca, Jamieson, Alzbeta, Hodsoll, John, Ferrier, Ian Nicol, McAllister-Williams, Richard Hamish, Powell, Timothy R., Young, Allan H., Cleare, Anthony J., Watson, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920038/
https://www.ncbi.nlm.nih.gov/pubmed/33669254
http://dx.doi.org/10.3390/jcm10040784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920038/
https://www.ncbi.nlm.nih.gov/pubmed/33669254
http://dx.doi.org/10.3390/jcm10040784

Ejemplares similares